Omicron and the markets

Posted by Doug Kinsey - 30 November, 2021

header-picture

Omicron and The Markets

Since last Friday, the emergence of the Omicron strain of the Covid virus has had an impact on the markets.  

As has been the case since the beginning of the global pandemic, we evaluate in real-time each headline surrounding mutations, infections, and potential impact on the health of human populations, global economics, and supply chain concerns in an effort to make decisions consistent with maintaining the financial health of our clients.

Thankfully, our partners at Goldman Sachs have proven to be an excellent resource in this effort.

Their economics research team published a Global Economics Comment yesterday entitled "Omicron and Global Growth."  We are making it available to our clients and friends to better understand the situation.

You can get your copy here:  Omicron and Global Growth.

For those of you who have taken advantage of our FinLife® service offering, you can access these reports when you log in to your GuideCenter portal under "Articles and Research" in the upper right corner of the home page.

If you are not already acquainted with this service from our firm, please reach out to Elizabeth Raby-Salinas at our office and she'll get you scheduled for the onboarding process.  You can email her at elizabeth@artifexfinancial.com to see if this is would be an appropriate solution for you.

 

Topics: markets, Covid-19, Goldman Sachs


Recent Posts

Happy Thanksgiving!

read more

Third Quarter Market Commentary

read more

L'Shana Tovah!

read more